Latelines for Aug. 4, 2003
FDA Issues CRL for Epidermolysis Bullosa Gene Therapy
Abeona Therapeutics’ pz-cel is an investigational autologous, COL7A1 gene-corrected epidermal sheet therapy for the treatment of recessive dystrophic epidermolysis bullosa.
Is E-Prescribing the Future of Veterinary Medicine?
Wendy Crouse, DVM, an independent house call veterinarian with Heal House Call Veterinarian, sat down with Drug Topics to discuss how the adoption of e-prescribing has transformed her practice.
Therapeutic Relationship Plays Key Role in Psychedelic Treatment
A higher patient-rated therapeutic alliance was associated with improvements in depression outcomes up to 1 year after treatment.
The Importance of Continuing Education in Pharmacy Compounding
Kevin Hope, RPh, senior director of pharmacy education at Pharmcon, joined Drug Topics to discuss pharmacy compounding from the new USP changes and the importance of education around compounding best practices.
Small Doses: April 15 to April 19
Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.
FDA Roundup: Biosimilars, Boxed Warning Added for CAR T-Cell Therapies
Check out important updates from the FDA for the week of April 15.
